Biospherex⢠LLC works in the field of human microbiome research, specializing in functional microbiomics and systems biology, and pioneering advances in microbial DNA sequencing methods, clinical research, and in-vitro diagnostics. Biospherex⢠has developed a new microbiomic diagnostics technology for early detection and monitoring of polymicrobial and immunological diseases such as inflammatory bowel disease, colon disease/cancer, HIV infection, and alcoholic liver disease. This new non-invasive diagnostic technology is less expensive, more sensitive, and more accurate than currently available diagnostic. Biospherex⢠LLC is a pioneer in human and environmental microbiome research and development specializing in functional microbiomics and systems biology applied to advances in microbial DNA sequencing methods, clinical research, and environmental microbiology. Patent pending microbial DNA analysis platforms and diagnostic technology provide the means to rapidly explore the human and environmental microbiome and drive discovery of new biomarkers, diagnostic, and therapeutic solutions in every field of metagenomic research and biotechnolo